Last updated on June 2019

A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer

Brief description of study

This study will evaluate the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple-negative breast cancer (TNBC).

Clinical Study Identifier: NCT03371017

Find a site near you

Start Over

The Valley Hospital

Paramus, NJ United States
  Connect »

Magee-Woman's Hospital

Pittsburgh, PA United States
  Connect »

Inova Schar Cancer Institute

Falls Church, VA United States
  Connect »


Villejuif, France
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

HCA Midwest Division

Kansas City, MO United States
  Connect »

Moscow City Oncology Hospital #62

Moscovskaya Oblast, Russian Federation
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.